MOR logo

MorphoSys AG (MOR) EBITDA

Annual EBITDA

-$76.35 M
-$228.82 M-150.08%

December 31, 2023


Summary


Performance

MOR EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherMORprofitabilitymetrics:

Quarterly EBITDA

$59.38 M
+$115.99 M+204.87%

December 31, 2023


Summary


Performance

MOR Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherMORprofitabilitymetrics:

TTM EBITDA

-$56.19 M
-$148.34 M-160.98%

December 31, 2023


Summary


Performance

MOR TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherMORprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

MOR EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-150.1%-71.4%-142.0%
3 y3 years-231.6%+143.0%-227.6%
5 y5 years-15.5%+143.0%-227.6%

MOR EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-150.1%+698.2%-71.4%-946.1%-129.0%+1221.5%
5 y5-year-150.1%+698.2%-76.1%-946.1%-129.0%+1221.5%
alltimeall time-150.1%+698.2%-76.1%-946.1%-129.0%+1221.5%

MorphoSys AG EBITDA History

DateAnnualQuarterlyTTM
Dec 2023
-$76.35 M(-150.1%)
$59.38 M(-204.9%)
-$56.19 M(-161.0%)
Sep 2023
-
-$56.62 M(+27.1%)
$92.15 M(-52.4%)
Jun 2023
-
-$44.55 M(+209.4%)
$193.59 M(+5.5%)
Mar 2023
-
-$14.40 M(-106.9%)
$183.51 M(+37.3%)
Dec 2022
$152.47 M(-125.0%)
$207.72 M(+363.4%)
$133.65 M(-123.2%)
Sep 2022
-
$44.83 M(-182.0%)
-$576.48 M(-19.3%)
Jun 2022
-
-$54.64 M(-15.0%)
-$713.98 M(-3.8%)
Mar 2022
-
-$64.26 M(-87.2%)
-$742.54 M(+6.8%)
Dec 2021
-$609.50 M(-1150.6%)
-$502.42 M(+442.1%)
-$695.26 M(+110.0%)
Sep 2021
-
-$92.67 M(+11.4%)
-$331.07 M(+22.2%)
Jun 2021
-
-$83.19 M(+389.8%)
-$270.85 M(+22.1%)
Mar 2021
-
-$16.98 M(-87.7%)
-$221.86 M(-604.0%)
Dec 2020
$58.02 M(-152.2%)
-$138.22 M(+325.9%)
$44.02 M(-64.7%)
Sep 2020
-
-$32.46 M(-5.1%)
$124.80 M(-5.2%)
Jun 2020
-
-$34.20 M(-113.7%)
$131.65 M(-18.5%)
Mar 2020
-
$248.90 M(-533.3%)
$161.58 M(-246.0%)
Dec 2019
-$111.11 M(+68.1%)
-$57.44 M(+124.3%)
-$110.66 M(+5.0%)
Sep 2019
-
-$25.61 M(+499.8%)
-$105.36 M(+143.8%)
Jun 2019
-
-$4.27 M(-81.7%)
-$43.22 M(-35.6%)
Mar 2019
-
-$23.34 M(-55.2%)
-$67.08 M(+1.6%)
Dec 2018
-$66.09 M(-7.2%)
-$52.15 M(-242.8%)
-$66.01 M(+128.6%)
Sep 2018
-
$36.53 M(-229.8%)
-$28.88 M(-68.4%)
Jun 2018
-
-$28.13 M(+26.3%)
-$91.24 M(+15.7%)
Mar 2018
-
-$22.27 M(+48.4%)
-$78.86 M(+10.6%)
Dec 2017
-$71.20 M(+14.7%)
-$15.01 M(-41.9%)
-$71.33 M(-17.1%)
Sep 2017
-
-$25.84 M(+64.0%)
-$86.06 M(+17.4%)
Jun 2017
-
-$15.75 M(+6.9%)
-$73.33 M(+9.7%)
Mar 2017
-
-$14.73 M(-50.5%)
-$66.86 M(+8.6%)
Dec 2016
-$62.07 M(-332.1%)
-$29.74 M(+126.8%)
-$61.56 M(+25.3%)
Sep 2016
-
-$13.11 M(+41.2%)
-$49.14 M(+4.2%)
Jun 2016
-
-$9.28 M(-1.6%)
-$47.17 M(+6.4%)
Mar 2016
-
-$9.43 M(-45.5%)
-$44.34 M(-257.1%)
Dec 2015
$26.74 M
-$17.31 M(+55.3%)
$28.23 M(-36.1%)
DateAnnualQuarterlyTTM
Sep 2015
-
-$11.15 M(+72.7%)
$44.18 M(-15.8%)
Jun 2015
-
-$6.45 M(-110.2%)
$52.47 M(-11.8%)
Mar 2015
-
$63.14 M(-4735.2%)
$59.51 M(>+9900.0%)
Dec 2014
-$74.80 K(-100.4%)
-$1.36 M(-52.3%)
$152.10 K(-105.2%)
Sep 2014
-
-$2.86 M(-590.1%)
-$2.92 M(+37.3%)
Jun 2014
-
$582.60 K(-84.6%)
-$2.13 M(-111.3%)
Mar 2014
-
$3.79 M(-185.4%)
$18.82 M(-6.6%)
Dec 2013
$20.64 M(+71.3%)
-$4.43 M(+115.0%)
$20.14 M(-37.5%)
Sep 2013
-
-$2.06 M(-109.6%)
$32.21 M(-9.3%)
Jun 2013
-
$21.52 M(+321.2%)
$35.49 M(+123.8%)
Mar 2013
-
$5.11 M(-33.1%)
$15.86 M(+31.0%)
Dec 2012
$12.05 M(-51.6%)
$7.63 M(+522.2%)
$12.11 M(-428.1%)
Sep 2012
-
$1.23 M(-35.1%)
-$3.69 M(-47.7%)
Jun 2012
-
$1.89 M(+39.7%)
-$7.05 M(-52.1%)
Mar 2012
-
$1.35 M(-116.6%)
-$14.73 M(-160.9%)
Dec 2011
$24.89 M(-2.8%)
-$8.16 M(+282.8%)
$24.18 M(-37.8%)
Sep 2011
-
-$2.13 M(-63.2%)
$38.85 M(-13.2%)
Jun 2011
-
-$5.79 M(-114.4%)
$44.77 M(-22.4%)
Mar 2011
-
$40.26 M(+518.2%)
$57.68 M(+124.2%)
Dec 2010
$25.62 M(-0.1%)
$6.51 M(+72.0%)
$25.73 M(+4.6%)
Sep 2010
-
$3.79 M(-46.8%)
$24.59 M(-9.5%)
Jun 2010
-
$7.11 M(-14.4%)
$27.16 M(+6.9%)
Mar 2010
-
$8.31 M(+54.5%)
$25.41 M(-0.0%)
Dec 2009
$25.65 M(-24.8%)
$5.38 M(-15.4%)
$25.42 M(+26.8%)
Sep 2009
-
$6.36 M(+18.4%)
$20.04 M(+46.4%)
Jun 2009
-
$5.37 M(-35.5%)
$13.69 M(+64.5%)
Mar 2009
-
$8.32 M
$8.32 M
Dec 2008
$34.10 M(+81.6%)
-
-
Dec 2007
$18.78 M(-82.9%)
-
-
Dec 2006
$109.81 M(+126.7%)
-
-
Dec 2005
$48.45 M(+1088.2%)
-
-
Dec 2004
$4.08 M(-471.1%)
-
-
Dec 2003
-$1.10 M(-95.0%)
-
-
Dec 2002
-$22.12 M
-
-

FAQ

  • What is MorphoSys AG annual EBITDA?
  • What is the all time high annual EBITDA for MorphoSys AG?
  • What is MorphoSys AG annual EBITDA year-on-year change?
  • What is MorphoSys AG quarterly EBITDA?
  • What is the all time high quarterly EBITDA for MorphoSys AG?
  • What is MorphoSys AG quarterly EBITDA year-on-year change?
  • What is MorphoSys AG TTM EBITDA?
  • What is the all time high TTM EBITDA for MorphoSys AG?
  • What is MorphoSys AG TTM EBITDA year-on-year change?

What is MorphoSys AG annual EBITDA?

The current annual EBITDA of MOR is -$76.35 M

What is the all time high annual EBITDA for MorphoSys AG?

MorphoSys AG all-time high annual EBITDA is $152.47 M

What is MorphoSys AG annual EBITDA year-on-year change?

Over the past year, MOR annual EBITDA has changed by -$228.82 M (-150.08%)

What is MorphoSys AG quarterly EBITDA?

The current quarterly EBITDA of MOR is $59.38 M

What is the all time high quarterly EBITDA for MorphoSys AG?

MorphoSys AG all-time high quarterly EBITDA is $248.90 M

What is MorphoSys AG quarterly EBITDA year-on-year change?

Over the past year, MOR quarterly EBITDA has changed by -$148.34 M (-71.41%)

What is MorphoSys AG TTM EBITDA?

The current TTM EBITDA of MOR is -$56.19 M

What is the all time high TTM EBITDA for MorphoSys AG?

MorphoSys AG all-time high TTM EBITDA is $193.59 M

What is MorphoSys AG TTM EBITDA year-on-year change?

Over the past year, MOR TTM EBITDA has changed by -$189.84 M (-142.04%)